• Regulatory NewsRegulatory News

    FDA seeks comment on device shortage reporting guidance

    The US Food and Drug Administration (FDA) on Monday released draft guidance on the new notification requirements for reporting medical device discontinuances and manufacturing interruptions created under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act).   The CARES Act was signed into law in the early months of the COVID-19 pandemic and, for the first time, established requirements for medical device makers to notify FDA of permanent discontinuances...